ADC Therapeutics to Participate in Morgan Stanley's 19th Annual Global Healthcare ConferenceBusiness Wire • 09/09/21
ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 MillionBusiness Wire • 08/26/21
ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/07/21
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/03/21
ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business UpdatesBusiness Wire • 08/03/21
ADC Therapeutics to Host Second Quarter 2021 Financial Results Conference Call on August 3, 2021Business Wire • 07/28/21
ADC Therapeutics Announces Encouraging Interim Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) Presented at the 16th Annual International Conference on Malignant LymphomaBusiness Wire • 06/22/21
ADC Therapeutics Presents Updated ZYNLONTA™ (loncastuximab tesirine-lpyl) Clinical Data at 16th Annual International Conference on Malignant LymphomaBusiness Wire • 06/18/21
Tuesday Analyst Upgrades and Downgrades: Campbell Soup, Exact Sciences, Exelixis, Spirit Airlines, Sarepta, ZTO and More24/7 Wall Street • 06/15/21
ADC Therapeutics Shareholders Approve All Resolutions at the Annual General MeetingBusiness Wire • 06/11/21
ADC Therapeutics Announces Presentations at the 16th Annual International Conference on Malignant LymphomaBusiness Wire • 06/09/21
ADC Therapeutics Announces Online Publication of Camidanlumab Tesirine Phase 1 Results in The Lancet HaematologyBusiness Wire • 05/26/21
ADC Therapeutics Announces Receipt of $50 Million Second Tranche of Convertible Credit Facility with DeerfieldBusiness Wire • 05/17/21
ADC Therapeutics Announces Online Publication of LOTIS-2 Results in The Lancet OncologyBusiness Wire • 05/12/21
ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21
ADC Therapeutics Reports First Quarter 2021 Financial Results and Provides Business UpdatesBusiness Wire • 05/06/21
ADC Therapeutics' ZYNLONTA™ (loncastuximab tesirine-lpyl) Added to National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology for B-cell LymphomasBusiness Wire • 05/05/21
ADC Therapeutics to Host First Quarter 2021 Financial Results Conference Call on May 6, 2021Business Wire • 04/29/21